Shares of LivaNova PLC (NASDAQ:LIVN) have been given an average recommendation of “Hold” by the nine analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $76.00.
LIVN has been the topic of a number of recent analyst reports. BidaskClub lowered LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Berenberg Bank reissued a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a research note on Friday, August 11th. WBB Securities lowered LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective on the stock. in a research note on Tuesday, August 15th. Needham & Company LLC initiated coverage on LivaNova PLC in a research note on Wednesday, August 23rd. They issued a “hold” rating on the stock. Finally, Jefferies Group LLC initiated coverage on LivaNova PLC in a research note on Friday, September 8th. They issued a “buy” rating and a $76.00 price objective on the stock.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total transaction of $60,760.00. Following the transaction, the director now owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 3,000 shares of company stock worth $203,890 in the last ninety days. 0.28% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently modified their holdings of LIVN. PNC Financial Services Group Inc. lifted its stake in shares of LivaNova PLC by 9.8% during the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after acquiring an additional 153 shares during the period. Riverhead Capital Management LLC lifted its stake in shares of LivaNova PLC by 76.3% during the second quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after acquiring an additional 763 shares during the period. Exane Derivatives lifted its stake in shares of LivaNova PLC by 814.8% during the second quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after acquiring an additional 2,811 shares during the period. Teacher Retirement System of Texas acquired a new position in shares of LivaNova PLC during the second quarter valued at $204,000. Finally, LS Investment Advisors LLC lifted its stake in shares of LivaNova PLC by 14.5% during the second quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock valued at $211,000 after acquiring an additional 436 shares during the period. 81.69% of the stock is currently owned by institutional investors and hedge funds.
Shares of LivaNova PLC (NASDAQ:LIVN) opened at $81.76 on Monday. The stock has a market cap of $3,941.78, a price-to-earnings ratio of 23.56, a price-to-earnings-growth ratio of 2.46 and a beta of 0.52. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.03 and a quick ratio of 1.42.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.17. The company had revenue of $309.70 million for the quarter, compared to analyst estimates of $301.22 million. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The business’s revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.78 earnings per share. equities analysts expect that LivaNova PLC will post 3.33 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://weekherald.com/2017/11/15/livanova-plc-livn-receives-consensus-recommendation-of-hold-from-analysts.html.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.